| 35917118 | Ustekinumab Tissue and Serum Levels in Patients With Crohn's Disease Are Closely Correlated Though Not Consistently Associated With Objective Response After Induction. | Inflamm Bowel Dis | 2023 |
| 34145969 | Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme. | FEBS J | 2022 |
| 35409342 | Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls. | Int J Mol Sci | 2022 |
| 33451129 | The Landscape of AhR Regulators and Coregulators to Fine-Tune AhR Functions. | Int J Mol Sci | 2021 |
| 33705545 | Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease. | Inflamm Bowel Dis | 2021 |
| 33693650 | Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation. | Hum Mol Genet | 2021 |
| 34394118 | Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity. | Front Immunol | 2021 |
| 34391570 | Editorial overview: Indoles: very busy (and not indolent) molecules at work in immune regulation. | Curr Opin Immunol | 2021 |
| 33968089 | Current Challenges for IDO2 as Target in Cancer Immunotherapy. | Front Immunol | 2021 |
| 34290243 | 3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine. | Nat Commun | 2021 |
| 31210557 | Effects of probiotic administration on immune responses of children and adolescents with type 1 diabetes to a quadrivalent inactivated influenza vaccine. | Hum Vaccin Immunother | 2020 |
| 32024760 | Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation. | Proc Natl Acad Sci U S A | 2020 |
| 33055013 | Polyamines and Kynurenines at the Intersection of Immune Modulation. | Trends Immunol | 2020 |
| 33159421 | Class IA PI3Ks regulate subcellular and functional dynamics of IDO1. | EMBO Rep | 2020 |
| 32605792 | A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function. | J Autoimmun | 2020 |
| 32994209 | Reply to Han et al.: On track for an IDO1-based personalized therapy in autoimmunity. | Proc Natl Acad Sci U S A | 2020 |
| 32899743 | Amino Acid Metabolism in Rheumatoid Arthritis: Friend or Foe? | Biomolecules | 2020 |
| 32546647 | Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma. | Clin Cancer Res | 2020 |
| 32428262 | Exemplifying complexity of immune suppression by a "canonical" speech: A glimpse into TNFRSF-activated signaling pathways in Treg cells. | Eur J Immunol | 2020 |
| 32190988 | New Insights from Crystallographic Data: Diversity of Structural Motifs and Molecular Recognition Properties between Groups of IDO1 Structures. | ChemMedChem | 2020 |
| 30793469 | IL-35Ig-expressing dendritic cells induce tolerance via Arginase 1. | J Cell Mol Med | 2019 |
| 31724832 | Tracking Hidden Binding Pockets Along the Molecular Recognition Path of l-Trp to Indoleamine 2,3-Dioxygenase 1. | ChemMedChem | 2019 |
| 31389262 | Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis. | Expert Opin Drug Discov | 2019 |
| 31354721 | Immunoregulatory Interplay Between Arginine and Tryptophan Metabolism in Health and Disease. | Front Immunol | 2019 |
| 31481962 | Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells. | Front Immunol | 2019 |
| 31337416 | Wolfram syndrome, a rare neurodegenerative disease: from pathogenesis to future treatment perspectives. | J Transl Med | 2019 |
| 30797943 | Amino acid metabolism as drug target in autoimmune diseases. | Autoimmun Rev | 2019 |
| 29563329 | Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes. | JCI Insight | 2018 |
| 29945890 | Loss of IDO1 Expression From Human Pancreatic β-Cells Precedes Their Destruction During the Development of Type 1 Diabetes. | Diabetes | 2018 |
| 30236470 | Immune Checkpoint Molecules, Personalized Immunotherapy, and Autoimmune Diabetes. | Trends Mol Med | 2018 |
| 30518925 | Induction of immunosuppressive functions and NF-κB by FLIP in monocytes. | Nat Commun | 2018 |
| 30391205 | Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1. | Biochem Pharmacol | 2018 |
| 30388851 | Is It Time to Use Probiotics to Prevent or Treat Obesity? | Nutrients | 2018 |
| 29486616 | Opportunities and challenges in drug discovery targeting metabotropic glutamate receptor 4. | Expert Opin Drug Discov | 2018 |
| 27696702 | Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. | J Cell Mol Med | 2017 |
| 30108849 | Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry. | Medchemcomm | 2017 |
| 28450863 | The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. | Front Immunol | 2017 |
| 28214225 | A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells. | Immunity | 2017 |
| 29031064 | Fragment-based approach to identify IDO1 inhibitor building blocks. | Eur J Med Chem | 2017 |
| 28771031 | Challenges in the design of reliable immuno-oncology mouse models to inform drug development. | Future Med Chem | 2017 |
| 28554057 | The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO. | Curr Opin Pharmacol | 2017 |
| 28825608 | Eating Disorders and Disordered Eating Symptoms in Adolescents with Type 1 Diabetes. | Nutrients | 2017 |
| 28545736 | Amino-acid sensing and degrading pathways in immune regulation. | Cytokine Growth Factor Rev | 2017 |
| 27647832 | IDO1 and TGF-β Mediate Protective Effects of IFN-α in Antigen-Induced Arthritis. | J Immunol | 2016 |
| 26522434 | Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells. | Neuropharmacology | 2016 |
| 25278421 | LPS-conditioned dendritic cells confer endotoxin tolerance contingent on tryptophan catabolism. | Immunobiology | 2015 |
| 26426076 | IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII. | J Clin Invest | 2015 |
| 26003759 | Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. | Cytokine | 2015 |
| 25783564 | Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1. | J Cell Mol Med | 2015 |
| 25729384 | The Coevolution of IDO1 and AhR in the Emergence of Regulatory T-Cells in Mammals. | Front Immunol | 2015 |